Last update of the site: January 20th, 2026
Kindie Yonatan 1 et al. | BMC Endocrine Disorders
Abstract Background Hormonal changes, particularly in estrogen and follicle-stimulating hormone, during the menopausal transition affect lipid and glucose metabolism, thereby
Li Ling 1 et al. | Lipids in Health and Disease
Abstract Background While specific unhealthy behavioral lifestyles link to primary dyslipidemia (PD), cumulative effects remain unknown. We quantified the association
Li Ling 1 et al. | Lipids in Health and Disease
Abstract Background While specific unhealthy behavioral lifestyles link to primary dyslipidemia (PD), cumulative effects remain unknown. We quantified the association
Francisco Martínez‐Mardones 1 et al. | British Journal of Clinical Pharmacology
Abstract Aims Cardiovascular diseases (CVD) are the primary cause of death in Chile. Pharmacist‐led medication review with follow‐up (MRF) has
Katzmann Julius L. et al. | Current Cardiology Reports
Abstract Purpose of Review Low-density lipoprotein cholesterol (LDL-C) is one major cause of cardiovascular disease (CVD). In this review, we
Tassew Worku Chekol 1 et al. | BMC Cardiovascular Disorders
Abstract Introduction Dyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant
Daghistani Hussam 1 et al. | Lipids in Health and Disease
Abstract Long noncoding RNAs (lncRNAs) have emerged as critical regulators of lipid metabolism, playing pivotal roles in cholesterol biosynthesis, transport,
Yang Ningjing 1 et al. | Lipids in Health and Disease
Abstract Background Primary healthcare (PHC) plays a key role in hyperlipidemia (HL) management yet lacks adequate monitoring and feedback. This
